Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/9911
Title: | IL-4 Can Inhibit IL-17 Production in Collagen Induced Arthritis |
Authors: | Shotorbani, Siamak Sandoghchian Zhang, Yue Baidoo, Samuel Essien Xu, Huaxi Ahmadi, Mohammad |
Keywords: | CIA, IL-4, IL-17 |
Issue Date: | Dec-2011 |
Publisher: | The Iranian Journal of Immunology is a quarterly Peer-Reviewed Journal |
Abstract: | Background: IL-4 is a cytokine that induces differentiation of naive helper T cells into Th2 cells. Once activated by IL-4, Th2 cells subsequently produce additional IL-4. Objective: To examine the effect of IL-4 on IL-17 production and its effect in Colla- gen-Induced Arthritis (CIA) mice. Method: In this study, a chicken collagen-II-induced experimental arthritis (CIA) model was used in DBA/1 mice to investigate the rela- tionship between IL-4 and IL-17 as well as other inflammatory factors. On the 38th day after the mice were induced with CIA, the expression of IL-17 and IL-4 as well as IFN-γ and IL-13 in sera of the mice was measured by QRT-PCR and ELISA. Result: The result of QRT-PCR analysis of IL-17 and IL-4 mRNA levels in the spleen showed that IL-17 is increased significantly at the onset of CIA in the spleen (p<0.01). Mean- while, IL-17 is generally reduced at the peak of CIA but IL-4 is increased significantly at this peak in the spleen (p<0.05) when the weight of the animal was taken into consid- eration. Conclusion: IL-4 can be involved in the production of IL-17 at especially the peak of CIA. These results imply that the inhibition of IL-17 may decrease the expres- sion of IL-1β and IL-6 production which will result in the aggravation of arthritis. |
URI: | http://hdl.handle.net/123456789/9911 |
Appears in Collections: | School of Allied Health Sciences |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Siamak Sandoghchian Shotorbani, Yue Zhang, Samuel Essien Baidoo,.pdf | Main article | 1.03 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.